促黄体生成素在辅助生殖技术应用中的研究进展
Research Progress on the Role of Luteinizing Hormone in Assisted Reproductive Technology
DOI: 10.12677/ACM.2024.141163, PDF,   
作者: 张艺鸥, 张觇宇*：重庆医科大学附属第二医院妇产科，重庆
关键词: 促黄体生成素；辅助生殖技术；Luteinzing Hormone； Assisted Reproductive Technology
摘要: 促黄体生成素是女性月经周期中的一种重要激素，它由垂体前叶脉冲式分泌。近年来，随着不孕症的发病率日益升高，LH在辅助生殖技术中的应用也颇为广泛，它是辅助生殖技术中备受关注的一项激素指标。控制性超促排卵是辅助生殖技术中的关键一环，促黄体生成素浓度过高或过低都可能导致不良的辅助生殖结局。国内外学者对黄体生成素的作用及其在辅助生殖技术的应用非常感兴趣，就此我将近年来关于黄体生成素的相关研究进展做个综述。
Abstract: Luteinizing hormone is an important hormone in a woman’s menstrual cycle, and it is secreted by the anterior pituitary gland in a pulsatile manner. In recent years, with the increasing incidence of infertility, LH has been widely used in assisted reproductive technology, which is a hormonal indi-cator that has attracted much attention in assisted reproductive technology. Controlled ovulation stimulation is a key part of assisted reproductive technology, and high or low luteinizing hormone concentrations can lead to adverse assisted reproductive outcomes. Scholars at home and abroad are very interested in the role of luteinizing hormone and its application in assisted reproductive technology, so I will review the relevant research progress of luteinizing hormone in recent years.
文章引用：张艺鸥, 张觇宇. 促黄体生成素在辅助生殖技术应用中的研究进展[J]. 临床医学进展, 2024, 14(1): 1130-1134. https://doi.org/10.12677/ACM.2024.141163

参考文献

[1] Howles, C.M. (2000) Role of LH and FSH in Ovarian Function. Molecular and Cellular Endocrinology, 161, 25-30. [Google Scholar] [CrossRef] 
[2] Naylor, S.L., Chin, W.W., Goodman, H.M., et al. (year) Chromosome Assignment of Genes Encoding the α and β Subunits of Glycoprotein Hormones in Man and Mouse. So-matic Cell Genetics, 6, 757-770.
[3] Shoham, Z., Homburg, R. and Jacobs, H.S. (1990) 11 Induction of Ovulation with Pulsatile GnRH. Baillière’s Clinical Obstetrics and Gynaecology, 4, 589-608. [Google Scholar] [CrossRef] 
[4] Falck, B. (1960) Site of Production of Oestrogen in Rat Ovary as Studied in Micro-Transplants. Acta Physiologica Scandinavica, 47, 1-101. [Google Scholar] [CrossRef] [PubMed]
[5] Hillier, S.G. (1994) Current Concepts of the Roles of Follicle Stimulating Hormone and Luteinizing Hormone in Folliculogenesis. Human Reproduction, 9, 188-191. [Google Scholar] [CrossRef] [PubMed]
[6] O’dea, L., O’brien, F., Currie, K., et al. (2008) Follic-ular Development Induced by Recombinant Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) in Anovulatory Women with LH and FSH Deficiency: Evidence of a Threshold Effect. Current Medical Research and Opinion, 24, 2785-2793. [Google Scholar] [CrossRef] [PubMed]
[7] Wong, P.C., Qiao, J., Ho, C., et al. (2011) Current Opinion on Use of Luteinizing Hormone Supplementation in Assisted Reproduction Therapy: An Asian Perspective. Reproductive BioMedicine Online, 23, 81-90. [Google Scholar] [CrossRef] [PubMed]
[8] The European Recombinant Human LH Study Group (1998) Re-combinant Human Luteinizing Hormone (LH) to Support Recombinant Human Follicle-Stimulating Hormone (FSH)-Induced Follicular Development in LH- and FSH-Deficient Anovulatory Women: A Dose-Finding Study. Jour-nal of Clinical Endocrinology and Metabolism, 83, Article 150714. [Google Scholar] [CrossRef] 
[9] Di Segni, N., Busnelli, A., Secchi, M., et al. (2022) Luteinizing Hormone Supplementation in Women with Hypogonadotropic Hypogonadism Seeking Fertility Care: Insights from a Narrative Review. Frontiers in Endocrinology, 13, Article 907249. [Google Scholar] [CrossRef] [PubMed]
[10] Nugent, D., Vanderkerchove, P., Hughes, E., et al. (2000) Gonadotrophin Therapy for Ovulation Induction in Subfertility Asso-ciated with Polycystic Ovary Syndrome. In The Cochrane Collaboration. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester. [Google Scholar] [CrossRef] 
[11] Hughes, E., Collins, J. and Vandekerckhove, P. (1996) Ovulation Induction with Urinary Follicle Stimulating Hormone versus Human Menopausal Gonadotropin for Clomiphene-Resistant Polycystic Ovary Syndrome. Cochrane Database of Systematic Reviews, 22. [Google Scholar] [CrossRef] 
[12] Lee, T.H., Lin, Y.H., Seow, K.M., et al. (2008) Effectiveness of Cetrorelix for the Prevention of Premature Luteinizing Hormone Surge during Controlled Ovarian Stimulation Using Letrozole and Gonadotropins: A Randomized Trial. Fertility and Sterility, 90, 113-120. [Google Scholar] [CrossRef] [PubMed]
[13] Sönmezer, M., Cil, A.P., Atabeko, C., et al. (2009) Does Premature Luteinization or Early Surge of LH Impair Cycle Outcome? Report of Two Successful Outcomes. Journal of Assisted Reproduction and Genetics, 26, 159-163. [Google Scholar] [CrossRef] [PubMed]
[14] 郑琪珍. 控制性促排卵中特殊人群添加重组人黄体生成素的临床应用[J]. 生殖医学杂志, 2019(1): 95-99.
[15] 叶红娟, 陈秋菊, 匡延平. 多囊卵巢综合征患者在高孕激素超促排卵中LH与IVF/ICSI临床结局的相关性分析[J]. 生殖与避孕, 2016, 36(3): 177-184.

为你推荐